1. Smalley RV: The management of disseminated breast cancer.In S Carter, R Livingston, E Glatstein (eds): Principles of Cancer Treatment. McGraw-Hill, New York, 1982, pp 327–341
2. Hoogstraten B: Adriamycin (NSC-123127) in the treatment of advanced breast cancer: studies by the Southwest Oncology Group. Cancer Chemother Rep Part 3 Vol 6: 329–334, 1975
3. Tormey DC: Adriamycin (NSC-123127) in breast cancer: an overview of studies. Cancer Chemother Rep, Part 3 Vol 6: 319–327, 1975
4. Smalley RV, Carpenter J, Bartolucci AA, Vogel C, Krauss S: A comparison of CAF (Cytoxan-Adriamycin-5-FU) and CMFOP (Cytoxan-Methotrexate-5-FU-Oncovin-Prednisone) in patients with metastatic breast cancer. Cancer 40: 625–632, 1977
5. Smalley RV, Bartolucci AA: Variation in responsiveness and survival of clinical subsets of patients with metastatic breast cancer to combination chemotherapy.In HT Mouridsen, T Palshof (eds.): Breast Cancer: Experimental & Clinical Aspects. Pergamon Press, Oxford, 1980, pp 141–146